Skip to content

Incidence of New-onset Diabetes Mellitus after COVID-19 Infection in Bangchak Hospital

Incidence of New-onset Diabetes Mellitus after COVID-19 Infection in Bangchak Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20240425002
Enrollment
601
Registered
2024-04-25
Start date
2023-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

new-onset diabetes after COVID-19 infection diabetes, steroids, coronavirus disease, COVID-19

Interventions

The patients were diagnosed diabetes with in 3 month after COVID-19 infection.,The patients were not diagnosed diabetes with in 3 month after COVID-19 infection.
Other,Other
new-onset diabetes patient,non-diabetes patient

Sponsors

Bangchak Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Diagnosed COVID-19 infection 2. Age more than 18 years-old 3. History of In-hospital patient 4. There was blood tested for the fasting plasma glucose or HbA1c level within 3 months after infection

Exclusion criteria

Exclusion criteria: 1. Diabetes patients 2. Initial fasting plasma glucose(FPG) more than 126 mg/dl or random plasma glucose more than 200 mg/dl or hemoglobinA1c more than 6.5%

Design outcomes

Primary

MeasureTime frame
incidence of new-onset diabetes 3 month after COVID-19 infection fasting blood glucose or hemoglobinA1c

Secondary

MeasureTime frame
risk factor for diabetes During COVID-19 infection clinical characteristic

Countries

Thailand

Contacts

Public ContactTharawut Mekthara

Bangchak Hospital

tharawut.mk789@gmail.com0632249289

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026